Marijuana is on track to move from the federal government's most restrictive drug category to a more permissive one, under a ...
The federal process resumes, bringing realistic prospects for 280E relief and expanded research and CBD access initiatives alongside continued limits on banking and listings, with a focus on credible ...
The Drug Enforcement Administration (DEA) says the marijuana rescheduling appeal process “remains pending” despite President ...